VAP prevention: non-pharmacological strategies

M. Valencia, G. Li Bassi, A. Torres

Source: Eur Respir Monogr 2011; 53: 83-97
Disease area: Respiratory critical care, Respiratory infections

Congress or journal article abstractFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Valencia, G. Li Bassi, A. Torres. VAP prevention: non-pharmacological strategies. Eur Respir Monogr 2011; 53: 83-97

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Relationship between tracheotomy and ventilator-associated pneumonia: a case control study
Source: Eur Respir J 2007; 30: 314-320
Year: 2007



VAP prevention: pharmacological strategies
Source: Eur Respir Mon 2011; 53: 74-82
Year: 2011


Efficacy of a ventilator bundle for the prevention of the ventilator-associated pneumonia
Source: Annual Congress 2011 - Mechanical ventilation and lung injury: new advances
Year: 2011

Empyema treatment: about drains, fibrinolytics and when to call the surgeon
Source: Annual Congress 2007 - PG16 - Management of pleural problems in your practice today
Year: 2007



The association of ventilator-associated pneumonia with the frequent exchange of endotracheal tube
Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Year: 2016


Prevention of VAP: role of the artificial airway, body position and setting the ventilator
Source: Eur Respir Mon 2012; 55: 153-168
Year: 2012


Invasive interventions: mini-trach and -tracheostomy – who is the adequate patient?
Source: Annual Congress 2005 - Management of airway hypersecretions
Year: 2005

Antibiotic use
Source: Annual Congress 2005 - Protocols in the critically ill patient
Year: 2005

Implications of identifying the pathogen in ventilator-associated pneumonia (VAP)
Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU
Year: 2013


Effect of de-escalation antibiotic therapy on hospital-acquired, ventilator associated, and healthcare-associated pneumonia: A systematic review and meta-analysis
Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Year: 2016

Non-antibiotic treatment for severe pneumonia?
Source: Annual Congress 2005 - Outcome in severe pneumonia
Year: 2005

Automatic control of the tracheal cuff pressure does not prevent ventilator-associated pneumonia (VAP)
Source: Annual Congress 2005 - Diagnosis and prognosis of ventilator associated pneumonia: the clinical track
Year: 2005


Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia
Source: Eur Respir J 2011; 37: 1332-1339
Year: 2011



Effectiveness and safety of a protocolized mechanical ventilation and weaning strategy of COPD patients by respiratory therapists
Source: Annual Congress 2013 –Mechanical ventilation and weaning
Year: 2013

Novel jet nebulizer/holding chamber for drug delivery to the deep lung
Source: International Congress 2016 – Pulmonary drug delivery
Year: 2016

Appropriateness and delay to initiate therapy in ventilator-associated pneumonia
Source: Eur Respir J 2006; 27: 158-164
Year: 2006



Who should treat these patients: intensivists or pneumologists?
Source: Annual Congress 2006 - PG6 - Respiratory failure: noninvasive ventilation and techniques of diagnosis for hypoxic respiratory failure
Year: 2006



Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines
Source: Eur Respir J 2003 Dec 01;22(6):876-882
Year: 2003